![Praxis Precision Medicines Inc](/common/images/company/N_PRAX.png)
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, fo... Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. Show more
BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.03 | 15.2527663268 | 46.09 | 53.63 | 45.6 | 314675 | 50.35578214 | CS |
4 | 18.93 | 55.3670663937 | 34.19 | 53.63 | 33.01 | 429703 | 42.95216755 | CS |
12 | 3.89 | 7.90168596384 | 49.23 | 58.4105 | 33.01 | 317625 | 44.34094502 | CS |
26 | 12.14 | 29.6242069302 | 40.98 | 67.21 | 33.01 | 253695 | 47.3673401 | CS |
52 | 35.12 | 195.111111111 | 18 | 67.21 | 12.75 | 455099 | 28.14715844 | CS |
156 | -199.03 | -78.9331746976 | 252.15 | 353.4 | 11.85 | 776011 | 48.85635984 | CS |
260 | -355.03 | -86.9851770183 | 408.15 | 914.2575 | 11.85 | 680565 | 84.92867095 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.